doktor.se ipo q1taylortech.eu
Business

Stockholm-based Doktor.se raised €50M and plans an IPO for 2022

Doktor.se, a digital healthcare platform with headquarters in Stockholm, has secured €50 million in a fresh round of funding that included Norron, Consensus Asset Management, Skabholmen Invest, and other unidentified institutional investors. Previous investor Oriola Corporation has consented to sell a portion of its shares as part of the agreement in order to complete the financing. As a result, one of the company’s biggest stockholders is still Oriola.

According to Doktor.se, the extra funding will be used to enhance the platform’s support for mental health and chronic disorders. An aggressive acquisition drive and the digitalization of physical clinics are also planned. Despite not being mentioned in the news statement, the business is also planning an IPO for Q1 2022, according to doktor.se. CEO and creator Martin Lindman states that their goal is to execute a listing during the first quarter of 2022.

Doktor.se, which was established in 2016, has surpassed rival Kry to rank as the second most installed doctor app in Europe, according to Appfigures. Through their nationwide network of physical facilities and their internationally accessible app, Doktor.se conducted over 1.2 million patient consultations throughout the course of 2020. Moreover, AniCura, a chain of veterinary hospitals, uses telemedicine in the Nordic countries, Belgium, in collaboration with Proximus, a telecommunications company, and in Brazil through ViBE, a digital healthcare provider. safetradebinaryoptions

Lindman says that by initiating communication with patients digitally, we both benefit the patient and society at large by saving time and resources. While conventional healthcare is alleviated, more people obtain care quicker. This frees up resources for people who genuinely require in-person consultations. The fact that we are able to provide patients with a blend of physical and digital healthcare makes us really proud of what we have accomplished.

Also, Read More About – Cyclopam Tablet